Florian Scotté (Villejuif)
Meeting Opening – Cancer Care, Go to the future – Maryam Lustberg (USA)
Long Term Safety – Paolo Bossi (Brescia)
Meet the experts Session – Triple Negative : Pathway’s problematics
Barbara Pistilli (Villejuif) – Gilles Freyer (Lyon)
Meet the experts Session – Non iron deficiency anemia in cancer
Mario Dicato (Luxembourg)
Meet the experts Session – Severe diarrhea and targeted therapies : management
Paolo Bossi (Brescia) – Florian Scotté (Villejuif)
New drugs and safety / Tumor localization – Mario Dicato (Luxembourg)
GI Safety – Jeffrey Crawford (USA)
SYMPOSIUM : Immunotherapy treatment challenges in a home care setting – Florian Scotté (Villejuif)
Skin : From innovative therapies to toxicities – Nicolas Meyer (Toulouse)
Digital Health, Next steps – Mario Di Palma (Villejuif)
Young Physician Award Jean Klastersky – Presentation of the top clinical cases – Jean Klastersky (Bruxelles) – Paolo Bossi (Brescia) – Ivan Krakowski (Bordeaux) – Richard Gralla (USA)
Long term safety 2 – Pere Gascon (Barcelona)
Cardio-Oncology : Managing cardiovascular toxicity – Fausto Roila (Perugia)
SYMPOSIUM
Improving the management of Iparps in clinical practice : a French delphi consensus
New Drugs and Safety / Tumor Localization – Matti Aapro (Genolier)
MASCC JASCC 2023 – Florian Scotté (Villejuif)
Survivorship : From patients to caregivers – Matti Aapro (Genolier)
Unscheduled Pathways – Christophe Massard (Villejuif)
CINV Lecture – Richard Gralla (USA)
Lecture : Communication approaches for challenging situations – Judith Nelson (USA)
Young Physician Award Jean Klastersky – The Award Ceremony – Jean Klastersky (Bruxelles) – Paolo Bossi (Brescia) – Ivan Krakowski (Bordeaux) – Richard Gralla (USA)
Conclusion – Florian Scotté (Villejuif)
Jean-Charles Soria (Washington D.C. USA)
Daily drugs; Antibiotics, IPP, Statins, steroids, etc – Denis Moro-Sibilot (Grenoble)
The gut microbiota in the modulation of anticancer drugs efficacy and toxicity : last data – Lisa De Rosa (Villejuif)
The impact of pandemic on Ethics and Cancer Care – Matti Aapro (Switzerland)
The impact on supportive management – Andrew Davies (UK)
Gynecology – Isabelle Ray-Coquard (Lyon)
Haemato-Oncology: Supportive care and Car T-cell therapy – Stéphane Chèze (Caen)
Urology – Yann Vano (Paris)
Definition and guidelines – Maryam Lustberg (USA)
Canto: A new model for research – Ines Vaz Luis (Villejuif)
Patient’s experience and unmet needs – Patient
Digital health for symptom monitoring – Ethan Basch (USA)
Running to daily practice – Fabrice Denis (Le Mans)
A review of digital programs – Paolo Bossi (Brescia)
From hospital to home care and back – Mario Di Palma (Paris)
Ariane Laparra-Ramakichenin (Le Kremlin-Bicêtre)
Raffaele Ratta (Suresnes)
Is cancer a matter of bad luck? – Mario Dicato (Luxembourg)
Different approaches: CINV, best association from acute to breakthrough – Richard Gralla (USA)
Controversies: Febrile Neutropenia, MASCC tool evidence vs ASCO – Jean Klastersky (Brussels), B. L. Rapoport (South Africa)
Young physician award Jean Klastersky – Presentation of the 3 first clinical cases
Young physician award Jean Klastersky – Presentation of the 3 last clinical cases
New drugs expected in the next future (CAR T, bispecific antibodies…) – Christophe Massard (Rennes)
New coming toxicities – Jean-Marie Michot (Villejuif)
Managing the safety – Olivier Lambotte (Le Kremlin-Bicêtre)
How to deal with frailty – Gilles Freyer (Lyon)
Long term toxicity: are they similar with the acute? – Edith Borcoman (Paris)
How to prevent / manage long term toxicity? – Delphine Loirat (Paris)
Monitoring interest – Paolo Bossi (Brescia)
Didier Mayeur (Dijon)
Gilles Freyer (Lyon)
Covid vaccination: The MDAnderson experience – Ishwaria Mohan Subbiah (USA)
Covid vaccine, what else? – Benjamin Wyplosz (Le Kremlin-Bicêtre)
Breast – Joseph Gligorov (Paris)
GI – Jérôme Desrame (Lyon)
Lung – Nicolas Girard (Paris)
Session Q/R
Ismail Elalamy (Paris)
Young physician award Jean Klastersky – Award ceremony
Why to discuss and when – the main sexual complaints – Marion Aupomerol (Villejuif)
How to discuss – Richard Berman (UK)
Let’s talk about sexual minorities: the ASCO survey – Charles Stewart Kamen (USA), Mandi Pratt-Chapman (USA), Shail Maingi (USA)
Session Q/R
Conclusion Day 1 – Florian Scotté (Villejuif)
Conclusion Day 2 – Florian Scotté (Villejuif)
Meeting opening
Covid-19 and cancer – Matti Aapro
Covid-19 feedback from Gustave Roussy: positive and negative – Fabrice Barlési
Discussion & feedback – Paolo Bossi, Richard Gralla, Andrew Davies
MASCC and Designated Centers of Excellence in Supportive Care in Cancer – Andrew Davies, Toshiaki Saeki
MASCC in 2020-2021 – Andrew Davies
Panel discussion on MASCC-Designated Centers of Excellence in Supportive Care in Cancer Italian, UK, French &, Russian experiences – Andrea Antonuzzo, Richard Berman, Florian Scotté, Anton Snegovoy
Conclusion and expectations for MASCC 2022 – Toshiaki Saeki
Methodological issues in Supportive care Research – Fausto Roila
Cannabinoids
Matti Aapro
Vox pop « patient’s words »
From recreational to therapeutic: levels of proof – Ivan Krakowski
Cannabis in cancerology: from proof to unmet needs – Antonio Vigano
Discussion
Synergies of innovative treatments: efficacy versus safety With the institutional support of MSD – Jean-Marie Michot
Anti-TNF + immune checkpoint inhibitors – Nicolas Noel
What happens next: CAR-T cells? – Jean-Marie Michot
What happens next: vaccines and other immunomodulators – Eric Tartour
Digestive toxicity and innovative treatments – Joël Epstein
Diarrhea – Paolo Bossi
Oral mucositis – Joël Epstein
Nausea/Vomiting – Richard Gralla
Young physician award Jean Klastersky
Presentation of the 3 first clinical cases
Moderators : Jean Klastersk, Paolo Bossi, Richard Berman, Richard Gralla, Ivan Krakowski, Karin Jordan
Young physician award Jean Klastersky
Presentation of the 3 last clinical cases
Moderators : Jean Klastersk, Paolo Bossi, Richard Berman, Richard Gralla, Ivan Krakowski, Karin Jordan
Microbiota– Jeffrey Crawford
Microbiota: what is the question? – Lisa Derosa
Microbiota and treatments efficacy / safety – Carolina Alves-Costa-Silva
Discussion
Whole Genome Amplification (WGA), Next-Generation Sequencing (NGS) and genetic predispositions to toxicities – Pere Gascon
Opinion of… – Stephen Sonis
Discussion
Covid-19 and news about the management of febrile neutropenia
Session with the institutional support of Biogaran – Gilles Freyer, Florian Scotté
Febrile neutropenia: GCSF and/or antibiotic prophylaxis
Session with the institutional support of Pfizer – Jean Klastersky
Opinion of … – Mario Dicato
Opinion of … – Fausto Roila
Pain – Maria DiPalma
Mechanical pains: new drugs – Ivan Krakowski
New drugs and standard of care in neuropathic pain – Berit Jordan
Complementary therapies (evidence-based medicine) – Stéphanie Trager
Discussion
Post-JEICT: recent data on anticoagulants in cancer – Ismail Elalamy
Young physician award Jean Klastersky
Award ceremony
Modérateurs : Jean Klastersk, Paolo Bossi, Richard Berman, Richard Gralla, Ivan Krakowski, Karin Jordan
Physical empowerment and cancer – Andreas Charalambous
Pre habilitation – Nicolas Barizien
Pre habilitation including Covid-19 – Thierry Bouillet
Ré-habilitation including Covid-19 – Antonio Vigano
Discussion
Conclusion
NOS
PARTENAIRES 2022
OUR
2022 PARTNERS
